Plus therapeutics to participate in the d. boral capital inaugural global conference

Houston, may 08, 2025 (globe newswire) -- plus therapeutics, inc. (nasdaq: pstv) (the “company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (cns) cancers, announces that it will participate in the d. boral capital inaugural global conference.
PSTV Ratings Summary
PSTV Quant Ranking